目的 为《中国药典》四部理化检验方法通则引入新方法新技术提供借鉴。方法 通过查阅各国新版药典中收载的药品理化检验方法通则(附录)、药典讨论组(PDG)的协调结果和国际人用药品注册技术协调会(ICH)指导原则,总结归纳了理化检验方法的概况、增修订及协调情况,并与2015年版《中国药典》四部相关检验方法收载情况进行初步对比。结果 各国新版药典对理化检验方法的增修订主要集中在元素杂质、光谱法和化学计量学,《中国药典》在鉴别试验、光谱及色谱法、杂质检查法、辅料功能性指标检测法等有可借鉴的方法技术。结论 《中国药典》应基于我国制药工业现状,遵循渐进和可持续发展原则引入药品检验新技术新方法,加强对药品的质量控制,提升药品可控性。
Abstract
OBJECTIVE To provide reference for introducing new methods and technologies to the physical and chemical testing methods general chapters in Chinese Pharmacopoeia Volume Ⅳ. METHODS By reviewing the general chapters of drug physical and chemical testing methods (appendices)in the new editions of European, US, Japanese and British Pharmacopoeias, the harmonization results of the Pharmacopoeia Discussion Group (PDG)and the guidelines of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), the authors summarized the overview and new, revised and harmonized texts of physical and chemical testing methods, and made a preliminary comparison with the related testing methods in Chinese Pharmacopoeia (2015 edition) Volume Ⅳ. RESULTS The new and revised text on the physical and chemical testing methods in the new editions of European, US, Japanese and British Pharmacopoeias are mainly concentrated in elements impurities, spectrometry and chemometrics. Chinese Pharmacopoeia can learn from the technology of identification tests, spectrometry and chromatography, impurities analysis and functionality-related characteristics of pharmaceutical excipients. CONCLUSION Chinese Pharmacopoeia should be based on the actual level of China's pharmaceutical industry, follow the principles of progressive and sustainable development, introducing new drug testing technologies and methods to strengthen the quality control of drugs and improve drug controllability.
关键词
药典 /
理化检验方法 /
通则 /
比较
{{custom_keyword}} /
Key words
pharmacopoeia /
physicochemical testing method /
general chapter /
comparison
{{custom_keyword}} /
中图分类号：
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] XIE R, FENG F. Progress on the application of mass spectrometry in pharmacopoeias of different countries[J]. Drug Stand China(中国药品标准), 2015, 16(5):336-340.
[2] Ch.P(2015)Vol Ⅳ (中国药典2015年版. 四部)[S]. 2015.
[3] EP (9.0)Vol Ⅰ[S]. 2016.
[4] USP (40)Vol Ⅰ[S]. 2017.
[5] JP (17)[S]. 2016.
[6] BP (2018)Vol Ⅴ[S]. 2018.
[7] BP (2017)Vol Ⅴ[S]. 2017.
[8] USP (39)Vol Ⅰ[S]. 2016.
[9] USP: USP-NF Cumulative List of Revisions Updated?[EB/OL]. [2017-12-29]. http://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/usp-nf-commentary/cumulative_ballot_results.xlsx.
[10] EDQM: Contents of the 9th Edition[EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/content-list-90.pdf.
[11] EDQM: Comments concerning revised texts published in the 9th Edition [EB/OL]. [2016-8] https://www.edqm.eu/sites/default/files/supplement-comments-90.pdf.
[12] EDQM: Contents of Supplement 9.1[EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/supplement-content-list-91.pdf.
[13] EDQM: Comments concerning revised texts published in Supplement 9.1 [EB/OL]. [2016-10] https://www.edqm.eu/sites/default/files/supplement-comments91.pdf.
[14] EDQM: Contents of Supplement 9.2 [EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/supplement_pheur-contents_9-2-2016.pdf.
[15] EDQM: Comments concerning revised texts published in Supplement 9.2 [EB/OL]. [2017-1] https://www.edqm.eu/sites/default/files/supplement-comments-92.pdf.
[16] EDQM: Contents of Supplement 9.3 [EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/supplement-pheur-contents_9-3-2017.pdf.
[17] EDQM: Comments concerning revised texts published in Supplement 9.3 [EB/OL]. [2017-6] https://www.edqm.eu/sites/default/files/supplementcomments93_e.pdf.
[18] JIANG X P, HONG X X. Introduction of general chapters of Chinese Pharmacopoeia 2015 Edition going to the new normal developing [J]. Chin Pharm J(中国药学杂志), 2015, 50(20):1787-1789.
[19] QIAN Y L, ZHAO C J, LU A X, et al. X-ray fluorescence spectroscopy and its research progress[J]. Farm Machinery (农业机械), 2011,(16):137-141.
[20] GAN D L, ZHOU C X. Vibrational circular dichroism: a new tool for the determination of absolute configuration of chiral molecules[J].Chin J Org Chem(有机化学), 2009, 29(6):848-857.
[21] BURGESS C, HAMMOND J P. Modernisation of the spectroscopic general chapters in the United States Pharmacopeia[J]. Spectrosc Eur, 2015, 27(1):26-29.
[22] WEI X M, WU Q, LIU Q, et al. Progress on application of chemonetrics-spectrometry in pharmaceutical analysis[J]. Chin J Pharm Anal(药物分析杂志), 2013(8):1447-1452.
[23] EDQM: New General Chapter on Chemical Imaging in the European Pharmacopoeia[EB/OL]. [2017-1-5]. https://www.edqm.eu/sites/default/files/pressrelease-pheur_new_chapter_chemical_imaging-january2017.pdf.
[24] EDQM: EDQM Annual Report 2016. [EB/OL].[2017-6-27]. https://www.edqm.eu/sites/default/files/annual_report_edqm_2016.pdf.
[25] LI Y, YU Z G, ZHANG J, et al. International certification of API on the elemental impurities[J]. Maschinen Markt(现代制造), 2017,(32):16-18.
[26] JIANG X L, DONG S P, SHU J N. Interpretation of key points of assessment and control of elemental impurities in new drug preparations for ICH Q3D guideline[J]. Chin Pharm Aff(中国药事), 2017, 31(8):854-860.
[27] YANG Z, HUANG X F. Recent progress in application of polarization spectrometer[J]. Guangzhou Chem Ind(广州化工), 2014, 42(11):44-45.
[28] CHU D J, JIANG H, HU M. Determination of thimerosal of chondroitin sulfate eye drops in different packing materials by volt-am-pere polarography method[J]. China Pharm(中国药师), 2017, 20(2):380-382.
[29] USP: Harmonization Status for General Chapters [2017-2-28]. http://www.usp.org/harmonized-standards/pdg/general-chapters.
[30] USP: Harmonization Status for General Methods [2017-2-28]. http://www.usp.org/harmonized-standards/pdg/general-methods.
[31] ICH Q4B: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions.[EB/OL].[2007-11-1]. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q4B/Step4/Q4B_Guideline.pdf.
[32] ICH: Q4-Q4B Pharmacopoeias [EB/OL]. [2017-8-11]. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html.
[33] LIU Y, WANG Z J, DONG X, et al. Application of residual solvents determination method in Chinese Pharmacopoeia 2015 Edition[J]. Chin Pharm J(中国药学杂志), 2017,52(17):1558-1562.
[34] LIU Y, WANG Z J, DONG X, et al. Progress in the control concepts and determination methods of residual solvents in pharmaceuticals[J]. Chin New Drug J(中国新药杂志), 2017,126(17):2040-2045.
[35] Chinese Pharmacopoeia Commission.Guidance on Analysis and Testing Technology of the Chinese Pharmacopoeia(中国药典分析检测技术指南)[M]. Beijing: China Medical Science Press, 2017: 420-424,487-491.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(1208 KB)
